Back to search
Tumor Hyperinsulinism (Tumor HI)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Tumor Hyperinsulinism (Tumor HI) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Tumor Hyperinsulinism (Tumor HI) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The objectives of this study are to evaluate the glycemic efficacy, safety, and tolerability of ersodetug as add-on to standard of care (SOC) therapy for treatm…
Low blood sugars are known to cause brain damage in newborn babies. One of the most common causes of low blood sugars persisting beyond the new born period is a…
This purpose of this study is to determine the ability of an 18F-fluoro-L-dihydroxyphenylalanine (18F-DOPA) PET (Positron Emission Tomography) scan to detect a…
This expanded access program is intended to provide ersodetug, an investigational drug, to eligible participants who suffer from inadequately controlled hypogly…